Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA: 688266)
China
· Delayed Price · Currency is CNY 61.58
+0.50 (0.82%)
Jan 3, 2025, 3:00 PM CST
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Revenue
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. had revenue of 143.42M CNY in the quarter ending September 30, 2024, with 130.67% growth. This brings the company's revenue in the last twelve months to 488.45M, up 26.37% year-over-year. In the year 2023, Suzhou Zelgen Biopharmaceuticals Co.,Ltd. had annual revenue of 386.44M with 27.83% growth.
Revenue (ttm)
488.45M
Revenue Growth
+26.37%
P/S Ratio
33.36
Revenue / Employee
563.38K
Employees
867
Market Cap
16.30B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |